SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form SC 13G - Statement of acquisition of beneficial ownership by individuals:
SEC Accession No. 0000932440-10-000075
Filing Date
2010-04-05
Accepted
2010-04-05 17:28:34
Documents
3
Group Members
RIDGEBACK CAPITAL INVESTMENTS LTD.RIDGEBACK CAPITAL MANAGEMENT LP

Document Format Files

Seq Description Document Type Size
1 SC 13G sc13-g_1407275.htm SC 13G 138028
2 POWER OF ATTORNEY ex24-1_1407261.htm EX-24.1 5438
3 JOINT FILING AGREEMENT ex99-1_1407262.htm EX-99.1 17183
  Complete submission text file 0000932440-10-000075.txt   162709
Mailing Address 8 SYLVAN WAY PARSIPPANY NJ 07054
Business Address 8 SYLVAN WAY PARSIPPANY NJ 07054 973-290-6000
MEDICINES CO /DE (Subject) CIK: 0001113481 (see all company filings)

IRS No.: 043324394 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 13G | Act: 34 | File No.: 005-60201 | Film No.: 10732336
SIC: 2834 Pharmaceutical Preparations

Mailing Address 430 PARK AVENUE 12TH FLOOR NEW YORK NY 10022
Business Address 430 PARK AVENUE 12TH FLOOR NEW YORK NY 10022 212-624-2567
Ridgeback Capital Investments L.P. (Filed by) CIK: 0001423994 (see all company filings)

IRS No.: 000000000 | State of Incorp.: E9 | Fiscal Year End: 1231
Type: SC 13G